These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1390333)

  • 41. Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction.
    Nasir N; Taylor A; Doyle TK; Pacifico A
    Am J Cardiol; 1994 Dec; 74(12):1183-6. PubMed ID: 7977086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog.
    Keren G; Tepper D; Butler B; Torres V; Somberg JC
    Am Heart J; 1984 Nov; 108(5):1236-43. PubMed ID: 6333809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of intravenous propranolol for suppression of inducibility of ventricular tachyarrhythmias with different electrophysiologic characteristics in coronary artery disease.
    Huikuri HV; Cox M; Interian A; Kessler KM; Glicksman F; Castellanos A; Myerburg RJ
    Am J Cardiol; 1989 Dec; 64(19):1305-9. PubMed ID: 2589196
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized crossover comparison of the electrophysiologic and antiarrhythmic efficacy of oral cibenzoline and sotalol for sustained ventricular tachycardia.
    Hoffmann E; Mattke S; Haberl R; Steinbeck G
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):95-100. PubMed ID: 7678686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained ventricular tachycardia in chronic chagasic myocarditis: electrophysiologic and pharmacologic characteristics.
    Mendoza I; Camardo J; Moleiro F; Castellanos A; Medina V; Gomez J; Acquatella H; Casal H; Tortoledo F; Puigbo J
    Am J Cardiol; 1986 Feb; 57(6):423-7. PubMed ID: 3946258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Electrophysiological anti-arrhythmia effects of tiracizine in ventricular tachycardia].
    Volkmann H; Kühnert H; Dannberg G; Heinke M; Leeder U; Popp U
    Z Gesamte Inn Med; 1991 Dec; 46(17):635-41. PubMed ID: 1776306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
    Man KC; Williamson BD; Niebauer M; Daoud E; Bakr O; Strickberger SA; Hummel JD; Kou W; Morady F
    Am J Cardiol; 1994 Dec; 74(11):1119-23. PubMed ID: 7977070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease.
    Pires LA; Wagshal AB; Greene TO; Mittleman RS; Huang SK
    Am J Cardiol; 1993 Oct; 72(12):908-10. PubMed ID: 8105674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Value and limitations of Holter monitoring and electrophysiologic testing in the evaluation of the treatment of sustained monomorphic ventricular tachycardia].
    Aouate P; Frank R; Fontaine G; Fillette F; Rougier I; Tonet J; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1990 Dec; 83(14):2031-7. PubMed ID: 2126710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective comparison of a conventional and an accelerated protocol for programmed ventricular stimulation in patients with coronary artery disease.
    Morady F; Kadish A; de Buitleir M; Kou WH; Calkins H; Schmaltz S; Rosenheck S; Sousa J
    Circulation; 1991 Mar; 83(3):764-73. PubMed ID: 1999027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective comparison of right and left ventricular stimulation for induction of sustained ventricular tachycardia.
    Lin HT; Mann DE; Luck JC; Krafchek J; Magro SA; Sakun V; Wyndham CR
    Am J Cardiol; 1987 Mar; 59(6):559-63. PubMed ID: 3825894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
    Haverkamp W; Martinez-Rubio A; Hief C; Lammers A; Mühlenkamp S; Wichter T; Breithardt G; Borggrefe M
    J Am Coll Cardiol; 1997 Aug; 30(2):487-95. PubMed ID: 9247523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy.
    Niwano S; Yamaura M; Yoshizawa N; Moriguchi M; Kitano Y; Aizawa Y; Izumi T
    Jpn Circ J; 1999 Sep; 63(9):674-80. PubMed ID: 10496481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
    Saksena S; Klein GJ; Kowey PR; Calvo RA; Boccadamo R; Brown JE; Sharma AD; Gadhoke A; Olukotun AY
    Am J Cardiol; 1987 Feb; 59(4):307-12. PubMed ID: 3812280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and electrophysiologic effects of flecainide in patients with refractory ventricular tachycardia.
    Capparelli EV; Kluger J; Regnier JC; Chow MS
    J Clin Pharmacol; 1988 Mar; 28(3):268-75. PubMed ID: 3129456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrophysiologic effects of bepridil in normal and infarcted canine myocardium.
    Lynch JJ; DiCarlo LA; Montgomery DG; Lucchesi BR
    J Cardiovasc Pharmacol; 1986; 8(5):957-66. PubMed ID: 2429097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiation and mechanisms of prevention and termination of verapamil-sensitive sustained ventricular tachycardia.
    Kasanuki H; Ohnishi S; Hosoda S
    Am J Cardiol; 1989 Dec; 64(20):46J-49J. PubMed ID: 2480708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
    Manolis AS; Uricchio F; Estes NA
    Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Estimation of the long-term efficacy of anti-arrhythmia treatment with flecainide in ventricular tachycardia].
    Fauchier JP; Cosnay P; Babuty B; Moquet B; Rouesnel P; Estepo J
    Arch Mal Coeur Vaiss; 1990 Jan; 83(1):77-83. PubMed ID: 2106308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.